Traditional Chinese medicine capable of chronic bronchitis and pulmonary heart disease

Abstract

The invention discloses a Chinese medicament for treating complicating cor pulmonale of chromic bronchitis, and belongs to the technical field of Chinese medicaments. The Chinese medicaments for treating the complicating cor pulmonale of chromic bronchitis comprises the following compositions in percentage by weight: 30 to 70 percent of Rhizoma Paridis and 30 to 70 percent of polygonatum odoratum, The Chinese medicament for treating the complicating cor pulmonale of chromic bronchitis adopts treatment principles of clearing heat and releasing toxin, relieving cough and asthma, and promoting production of body fluid and nourishing the lung, can clear heat and release toxin, relieve cough and asthma, and dispel wind and relieve convulsion, has good effect of relieving asthma, and has the characteristics of regulating qi and blood, making people in robust and sturdy good health, moistening heart and lungs, nourishing general debility and no toxic and side effect.

Description

A traditional Chinese medicine for treating chronic bronchitis complicated with cor pulmonale technical field The invention belongs to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating chronic bronchitis complicated with cor pulmonale. Background technique In the early stage of chronic bronchitis, the cilia of airway epithelial cells adhere, lodging, and loss, and epithelial cells degeneration, necrosis, hyperplasia, and squamous metaplasia occur. In patients with a long-term and severe condition, the inflammation spreads from the bronchial wall to the surrounding, and the smooth muscle bundle of the submucosa breaks and atrophies. When the lesion develops to an advanced stage, the mucosa has atrophic changes, and the fibrous tissue around the trachea proliferates, resulting in stiffness or collapse of the lumen. Lesions spread to the bronchioles and alveolar walls, resulting in structural destruction of lung...

AI Technical Summary

Problems solved by technology

At present, the treatment of chronic bronchitis complicated with cor pulmonale mainly adopts antibiotics, aminophylline and cedilan. Classes and digitalis drugs have high toxicity and side effects, and many patients cannot tolerate them.

Long-term use of aminophyllines reduces cough and asthma effects, and increases the toxicity of the dose, which is limited to less than 1g per day, and overdose can lead to death of the patient

Patients with cor pulmonale are very cautious in using digitalis drugs. Due to hypoxia, patients have very low tolerance to digitalis. A little carelessness can cause poisoning or even death in patients, so the clinical application is limited.

Images